Medical Care

Global Point of Care Molecular Diagnostics Technology Market Research Report 2025

The global market for Point of Care Molecular Diagnostics Technology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Point of Care Molecular Diagnostics Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care Molecular Diagnostics Technology.
The Point of Care Molecular Diagnostics Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Point of Care Molecular Diagnostics Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care Molecular Diagnostics Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Accelerate Diagnostics
Ador Diagnostics
Beckman Coulter
Becton, Dickinson and Company
Binx Health
Biocartis
bioMérieux
Bio-Rad Laboratories
Bosch Healthcare Solutions
Curetis
Eurofins Scientific
Genetic Signatures
Grifols
Hibergene Diagnostics
Lumos Diagnostics
Roche
Siemens
Thermo Fisher Scientific
Segment by Type
Polymerase Chain Reaction
In Situ Hybridization
Gene Chips
Next Generation Sequencing
Segment by Application
Hospitals and Clinics
Independent Clinical Laboratories
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Point of Care Molecular Diagnostics Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Molecular Diagnostics Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction
1.2.3 In Situ Hybridization
1.2.4 Gene Chips
1.2.5 Next Generation Sequencing
1.3 Market by Application
1.3.1 Global Point of Care Molecular Diagnostics Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Independent Clinical Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Molecular Diagnostics Technology Market Perspective (2020-2031)
2.2 Global Point of Care Molecular Diagnostics Technology Growth Trends by Region
2.2.1 Global Point of Care Molecular Diagnostics Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Point of Care Molecular Diagnostics Technology Historic Market Size by Region (2020-2025)
2.2.3 Point of Care Molecular Diagnostics Technology Forecasted Market Size by Region (2026-2031)
2.3 Point of Care Molecular Diagnostics Technology Market Dynamics
2.3.1 Point of Care Molecular Diagnostics Technology Industry Trends
2.3.2 Point of Care Molecular Diagnostics Technology Market Drivers
2.3.3 Point of Care Molecular Diagnostics Technology Market Challenges
2.3.4 Point of Care Molecular Diagnostics Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Molecular Diagnostics Technology Players by Revenue
3.1.1 Global Top Point of Care Molecular Diagnostics Technology Players by Revenue (2020-2025)
3.1.2 Global Point of Care Molecular Diagnostics Technology Revenue Market Share by Players (2020-2025)
3.2 Global Point of Care Molecular Diagnostics Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Point of Care Molecular Diagnostics Technology Revenue
3.4 Global Point of Care Molecular Diagnostics Technology Market Concentration Ratio
3.4.1 Global Point of Care Molecular Diagnostics Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Molecular Diagnostics Technology Revenue in 2024
3.5 Global Key Players of Point of Care Molecular Diagnostics Technology Head office and Area Served
3.6 Global Key Players of Point of Care Molecular Diagnostics Technology, Product and Application
3.7 Global Key Players of Point of Care Molecular Diagnostics Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Molecular Diagnostics Technology Breakdown Data by Type
4.1 Global Point of Care Molecular Diagnostics Technology Historic Market Size by Type (2020-2025)
4.2 Global Point of Care Molecular Diagnostics Technology Forecasted Market Size by Type (2026-2031)
5 Point of Care Molecular Diagnostics Technology Breakdown Data by Application
5.1 Global Point of Care Molecular Diagnostics Technology Historic Market Size by Application (2020-2025)
5.2 Global Point of Care Molecular Diagnostics Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Point of Care Molecular Diagnostics Technology Market Size (2020-2031)
6.2 North America Point of Care Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Point of Care Molecular Diagnostics Technology Market Size by Country (2020-2025)
6.4 North America Point of Care Molecular Diagnostics Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Molecular Diagnostics Technology Market Size (2020-2031)
7.2 Europe Point of Care Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Point of Care Molecular Diagnostics Technology Market Size by Country (2020-2025)
7.4 Europe Point of Care Molecular Diagnostics Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size (2020-2031)
8.2 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care Molecular Diagnostics Technology Market Size (2020-2031)
9.2 Latin America Point of Care Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Point of Care Molecular Diagnostics Technology Market Size by Country (2020-2025)
9.4 Latin America Point of Care Molecular Diagnostics Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size (2020-2031)
10.2 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Point of Care Molecular Diagnostics Technology Introduction
11.1.4 Abbott Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Details
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Point of Care Molecular Diagnostics Technology Introduction
11.2.4 Accelerate Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.2.5 Accelerate Diagnostics Recent Development
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Details
11.3.2 Ador Diagnostics Business Overview
11.3.3 Ador Diagnostics Point of Care Molecular Diagnostics Technology Introduction
11.3.4 Ador Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.3.5 Ador Diagnostics Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Point of Care Molecular Diagnostics Technology Introduction
11.4.4 Beckman Coulter Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.4.5 Beckman Coulter Recent Development
11.5 Becton, Dickinson and Company
11.5.1 Becton, Dickinson and Company Company Details
11.5.2 Becton, Dickinson and Company Business Overview
11.5.3 Becton, Dickinson and Company Point of Care Molecular Diagnostics Technology Introduction
11.5.4 Becton, Dickinson and Company Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.5.5 Becton, Dickinson and Company Recent Development
11.6 Binx Health
11.6.1 Binx Health Company Details
11.6.2 Binx Health Business Overview
11.6.3 Binx Health Point of Care Molecular Diagnostics Technology Introduction
11.6.4 Binx Health Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.6.5 Binx Health Recent Development
11.7 Biocartis
11.7.1 Biocartis Company Details
11.7.2 Biocartis Business Overview
11.7.3 Biocartis Point of Care Molecular Diagnostics Technology Introduction
11.7.4 Biocartis Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.7.5 Biocartis Recent Development
11.8 bioMérieux
11.8.1 bioMérieux Company Details
11.8.2 bioMérieux Business Overview
11.8.3 bioMérieux Point of Care Molecular Diagnostics Technology Introduction
11.8.4 bioMérieux Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.8.5 bioMérieux Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Point of Care Molecular Diagnostics Technology Introduction
11.9.4 Bio-Rad Laboratories Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Bosch Healthcare Solutions
11.10.1 Bosch Healthcare Solutions Company Details
11.10.2 Bosch Healthcare Solutions Business Overview
11.10.3 Bosch Healthcare Solutions Point of Care Molecular Diagnostics Technology Introduction
11.10.4 Bosch Healthcare Solutions Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.10.5 Bosch Healthcare Solutions Recent Development
11.11 Curetis
11.11.1 Curetis Company Details
11.11.2 Curetis Business Overview
11.11.3 Curetis Point of Care Molecular Diagnostics Technology Introduction
11.11.4 Curetis Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.11.5 Curetis Recent Development
11.12 Eurofins Scientific
11.12.1 Eurofins Scientific Company Details
11.12.2 Eurofins Scientific Business Overview
11.12.3 Eurofins Scientific Point of Care Molecular Diagnostics Technology Introduction
11.12.4 Eurofins Scientific Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.12.5 Eurofins Scientific Recent Development
11.13 Genetic Signatures
11.13.1 Genetic Signatures Company Details
11.13.2 Genetic Signatures Business Overview
11.13.3 Genetic Signatures Point of Care Molecular Diagnostics Technology Introduction
11.13.4 Genetic Signatures Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.13.5 Genetic Signatures Recent Development
11.14 Grifols
11.14.1 Grifols Company Details
11.14.2 Grifols Business Overview
11.14.3 Grifols Point of Care Molecular Diagnostics Technology Introduction
11.14.4 Grifols Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.14.5 Grifols Recent Development
11.15 Hibergene Diagnostics
11.15.1 Hibergene Diagnostics Company Details
11.15.2 Hibergene Diagnostics Business Overview
11.15.3 Hibergene Diagnostics Point of Care Molecular Diagnostics Technology Introduction
11.15.4 Hibergene Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.15.5 Hibergene Diagnostics Recent Development
11.16 Lumos Diagnostics
11.16.1 Lumos Diagnostics Company Details
11.16.2 Lumos Diagnostics Business Overview
11.16.3 Lumos Diagnostics Point of Care Molecular Diagnostics Technology Introduction
11.16.4 Lumos Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.16.5 Lumos Diagnostics Recent Development
11.17 Roche
11.17.1 Roche Company Details
11.17.2 Roche Business Overview
11.17.3 Roche Point of Care Molecular Diagnostics Technology Introduction
11.17.4 Roche Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.17.5 Roche Recent Development
11.18 Siemens
11.18.1 Siemens Company Details
11.18.2 Siemens Business Overview
11.18.3 Siemens Point of Care Molecular Diagnostics Technology Introduction
11.18.4 Siemens Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.18.5 Siemens Recent Development
11.19 Thermo Fisher Scientific
11.19.1 Thermo Fisher Scientific Company Details
11.19.2 Thermo Fisher Scientific Business Overview
11.19.3 Thermo Fisher Scientific Point of Care Molecular Diagnostics Technology Introduction
11.19.4 Thermo Fisher Scientific Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025)
11.19.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Point of Care Molecular Diagnostics Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Polymerase Chain Reaction
Table 3. Key Players of In Situ Hybridization
Table 4. Key Players of Gene Chips
Table 5. Key Players of Next Generation Sequencing
Table 6. Global Point of Care Molecular Diagnostics Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Point of Care Molecular Diagnostics Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Point of Care Molecular Diagnostics Technology Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Point of Care Molecular Diagnostics Technology Market Share by Region (2020-2025)
Table 10. Global Point of Care Molecular Diagnostics Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Point of Care Molecular Diagnostics Technology Market Share by Region (2026-2031)
Table 12. Point of Care Molecular Diagnostics Technology Market Trends
Table 13. Point of Care Molecular Diagnostics Technology Market Drivers
Table 14. Point of Care Molecular Diagnostics Technology Market Challenges
Table 15. Point of Care Molecular Diagnostics Technology Market Restraints
Table 16. Global Point of Care Molecular Diagnostics Technology Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Point of Care Molecular Diagnostics Technology Market Share by Players (2020-2025)
Table 18. Global Top Point of Care Molecular Diagnostics Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Molecular Diagnostics Technology as of 2024)
Table 19. Ranking of Global Top Point of Care Molecular Diagnostics Technology Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Point of Care Molecular Diagnostics Technology Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Point of Care Molecular Diagnostics Technology, Headquarters and Area Served
Table 22. Global Key Players of Point of Care Molecular Diagnostics Technology, Product and Application
Table 23. Global Key Players of Point of Care Molecular Diagnostics Technology, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Point of Care Molecular Diagnostics Technology Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Point of Care Molecular Diagnostics Technology Revenue Market Share by Type (2020-2025)
Table 27. Global Point of Care Molecular Diagnostics Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Point of Care Molecular Diagnostics Technology Revenue Market Share by Type (2026-2031)
Table 29. Global Point of Care Molecular Diagnostics Technology Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Point of Care Molecular Diagnostics Technology Revenue Market Share by Application (2020-2025)
Table 31. Global Point of Care Molecular Diagnostics Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Point of Care Molecular Diagnostics Technology Revenue Market Share by Application (2026-2031)
Table 33. North America Point of Care Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Point of Care Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Point of Care Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Point of Care Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Point of Care Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Point of Care Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Point of Care Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Point of Care Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Point of Care Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Company Details
Table 49. Abbott Business Overview
Table 50. Abbott Point of Care Molecular Diagnostics Technology Product
Table 51. Abbott Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Accelerate Diagnostics Company Details
Table 54. Accelerate Diagnostics Business Overview
Table 55. Accelerate Diagnostics Point of Care Molecular Diagnostics Technology Product
Table 56. Accelerate Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 57. Accelerate Diagnostics Recent Development
Table 58. Ador Diagnostics Company Details
Table 59. Ador Diagnostics Business Overview
Table 60. Ador Diagnostics Point of Care Molecular Diagnostics Technology Product
Table 61. Ador Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 62. Ador Diagnostics Recent Development
Table 63. Beckman Coulter Company Details
Table 64. Beckman Coulter Business Overview
Table 65. Beckman Coulter Point of Care Molecular Diagnostics Technology Product
Table 66. Beckman Coulter Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 67. Beckman Coulter Recent Development
Table 68. Becton, Dickinson and Company Company Details
Table 69. Becton, Dickinson and Company Business Overview
Table 70. Becton, Dickinson and Company Point of Care Molecular Diagnostics Technology Product
Table 71. Becton, Dickinson and Company Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 72. Becton, Dickinson and Company Recent Development
Table 73. Binx Health Company Details
Table 74. Binx Health Business Overview
Table 75. Binx Health Point of Care Molecular Diagnostics Technology Product
Table 76. Binx Health Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 77. Binx Health Recent Development
Table 78. Biocartis Company Details
Table 79. Biocartis Business Overview
Table 80. Biocartis Point of Care Molecular Diagnostics Technology Product
Table 81. Biocartis Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 82. Biocartis Recent Development
Table 83. bioMérieux Company Details
Table 84. bioMérieux Business Overview
Table 85. bioMérieux Point of Care Molecular Diagnostics Technology Product
Table 86. bioMérieux Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 87. bioMérieux Recent Development
Table 88. Bio-Rad Laboratories Company Details
Table 89. Bio-Rad Laboratories Business Overview
Table 90. Bio-Rad Laboratories Point of Care Molecular Diagnostics Technology Product
Table 91. Bio-Rad Laboratories Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 92. Bio-Rad Laboratories Recent Development
Table 93. Bosch Healthcare Solutions Company Details
Table 94. Bosch Healthcare Solutions Business Overview
Table 95. Bosch Healthcare Solutions Point of Care Molecular Diagnostics Technology Product
Table 96. Bosch Healthcare Solutions Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 97. Bosch Healthcare Solutions Recent Development
Table 98. Curetis Company Details
Table 99. Curetis Business Overview
Table 100. Curetis Point of Care Molecular Diagnostics Technology Product
Table 101. Curetis Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 102. Curetis Recent Development
Table 103. Eurofins Scientific Company Details
Table 104. Eurofins Scientific Business Overview
Table 105. Eurofins Scientific Point of Care Molecular Diagnostics Technology Product
Table 106. Eurofins Scientific Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 107. Eurofins Scientific Recent Development
Table 108. Genetic Signatures Company Details
Table 109. Genetic Signatures Business Overview
Table 110. Genetic Signatures Point of Care Molecular Diagnostics Technology Product
Table 111. Genetic Signatures Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 112. Genetic Signatures Recent Development
Table 113. Grifols Company Details
Table 114. Grifols Business Overview
Table 115. Grifols Point of Care Molecular Diagnostics Technology Product
Table 116. Grifols Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 117. Grifols Recent Development
Table 118. Hibergene Diagnostics Company Details
Table 119. Hibergene Diagnostics Business Overview
Table 120. Hibergene Diagnostics Point of Care Molecular Diagnostics Technology Product
Table 121. Hibergene Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 122. Hibergene Diagnostics Recent Development
Table 123. Lumos Diagnostics Company Details
Table 124. Lumos Diagnostics Business Overview
Table 125. Lumos Diagnostics Point of Care Molecular Diagnostics Technology Product
Table 126. Lumos Diagnostics Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 127. Lumos Diagnostics Recent Development
Table 128. Roche Company Details
Table 129. Roche Business Overview
Table 130. Roche Point of Care Molecular Diagnostics Technology Product
Table 131. Roche Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 132. Roche Recent Development
Table 133. Siemens Company Details
Table 134. Siemens Business Overview
Table 135. Siemens Point of Care Molecular Diagnostics Technology Product
Table 136. Siemens Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 137. Siemens Recent Development
Table 138. Thermo Fisher Scientific Company Details
Table 139. Thermo Fisher Scientific Business Overview
Table 140. Thermo Fisher Scientific Point of Care Molecular Diagnostics Technology Product
Table 141. Thermo Fisher Scientific Revenue in Point of Care Molecular Diagnostics Technology Business (2020-2025) & (US$ Million)
Table 142. Thermo Fisher Scientific Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report


List of Figures
Figure 1. Point of Care Molecular Diagnostics Technology Picture
Figure 2. Global Point of Care Molecular Diagnostics Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Point of Care Molecular Diagnostics Technology Market Share by Type: 2024 VS 2031
Figure 4. Polymerase Chain Reaction Features
Figure 5. In Situ Hybridization Features
Figure 6. Gene Chips Features
Figure 7. Next Generation Sequencing Features
Figure 8. Global Point of Care Molecular Diagnostics Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Point of Care Molecular Diagnostics Technology Market Share by Application: 2024 VS 2031
Figure 10. Hospitals and Clinics Case Studies
Figure 11. Independent Clinical Laboratories Case Studies
Figure 12. Point of Care Molecular Diagnostics Technology Report Years Considered
Figure 13. Global Point of Care Molecular Diagnostics Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Point of Care Molecular Diagnostics Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Point of Care Molecular Diagnostics Technology Market Share by Region: 2024 VS 2031
Figure 16. Global Point of Care Molecular Diagnostics Technology Market Share by Players in 2024
Figure 17. Global Top Point of Care Molecular Diagnostics Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Molecular Diagnostics Technology as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Point of Care Molecular Diagnostics Technology Revenue in 2024
Figure 19. North America Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Point of Care Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 21. United States Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Point of Care Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 25. Germany Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Point of Care Molecular Diagnostics Technology Market Share by Region (2020-2031)
Figure 33. China Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Point of Care Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 41. Mexico Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Point of Care Molecular Diagnostics Technology Market Share by Country (2020-2031)
Figure 45. Turkey Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Point of Care Molecular Diagnostics Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 49. Accelerate Diagnostics Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 50. Ador Diagnostics Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 51. Beckman Coulter Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 52. Becton, Dickinson and Company Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 53. Binx Health Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 54. Biocartis Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 55. bioMérieux Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 57. Bosch Healthcare Solutions Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 58. Curetis Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 59. Eurofins Scientific Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 60. Genetic Signatures Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 61. Grifols Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 62. Hibergene Diagnostics Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 63. Lumos Diagnostics Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 64. Roche Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 65. Siemens Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Point of Care Molecular Diagnostics Technology Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies